Overview
Applied research with analytical depth and confidentiality built in.
Staff members at ELI have established expertise in analysis of a variety of drugs and their metabolites, including marijuana and cannabinoids, coca and cocaine, opiates, barbiturates, amphetamines, phencyclidine, benzodiazepines, gamma hydroxybutyrate, and other drugs of abuse.
Technical staff members are well trained and have participated in a variety of research projects in the drug abuse area. The team understands the importance and implications of drug testing and research, including the forensic and confidentiality aspects of the work.
Selected Patents
Selected examples of patented research and development work.
- Salamone, Courtney, Stocker, ElSohly, and Gul; Taxol Immunoassay, U.S. Patent 7,175,993 B2, issued February 13, 2007.
- ElSohly, Ross, and Galal; Dihydroartemisinin and Dihydroartemisitene Dimers as Anti-Cancer and Anti-Infective Agents, U.S. Patent 7,098,242, issued August 29, 2006.
- ElSohly and Gul; Anticancer and Antiprotozoal Dihydroartemisinin and Dihydroartemisitene Dimers with Desirable Chemical Functionalities, European Patent WO 2006/002105 A1, issued January 5, 2006.
- ElSohly, Ross, and Galal; Dihydroartemisinin and Dihydroartemisitene Dimers as Anti-Cancer and Anti-Infective Agents, U.S. Patent 6,790,863 B2, issued September 14, 2004.
- Pasco, Pugh, Ross, and ElSohly; Potent Immunostimulants from Micro-Algae, South African Patent No. 2003/1050 and New Zealand Patent No. 523695, issued 2004.
- ElSohly, Ross, and Feng; Method of Preparing delta-9-tetrahydrocannabinol esters, Australia Patent No. 770382, issued June 17, 2004.
- ElSohly and Ross; Method of preparing delta-9-tetrahydrocannabinol, Australia Patent No. 763700, issued November 13, 2003.
- ElSohly and Ross; Method of preparing delta-9-tetrahydrocannabinol, U.S. Patent 6,365,416 B1, issued April 2, 2002.
- ElSohly, Ross, and Feng; Method of Preparing delta-9-tetrahydrocannabinol esters, U.S. Patent 6,008,383, issued December 28, 1999.
- ElSohly; Stable Suppository Formulations Effecting Bioavailability of Delta-9-THC, U.S. Patent 5,509,037, issued April 16, 1996.
Financial Conflict of Interest Policy
ELI's Financial Conflict of Interest policy is available as a downloadable PDF.